Skip to main content
. 2019 Sep 20;39(9):BSR20190159. doi: 10.1042/BSR20190159

Figure 6. Isorhamnetin inhibits phosphorylation of ERK and Akt in A549 cells.

Figure 6

(A) Effects of Isorhamnetin (2.5, 5, and 10 μM) on the protein expression of phosphor-Akt, Akt, phosphor-ERK1/2, ERK1/2, phosphor-JNK1/2, JNK1/2, phosphor-p38, and p38 of A549 lung cancer cells. (B) Quantitative result of phosphor-Akt, Akt, phosphor-ERK1/2, ERK1/2, phosphor-JNK1/2, JNK1/2, phosphor-p38, and p38 proteins expression of A549 lung cancer cells. Bars represent mean ± S.D. (n=3). *P<0.05, **P<0.01, and ***P<0.001 were considered to indicate a statistically significant difference compared with the control.